Skip to main content

Femtosecond label-free imaging: A rapid and reliable alternative for intraoperative pathological assessment in thoracic oncology

In brief

Femtosecond imaging reduces intraoperative pathology time from 36 to 5 minutes

In a prospective series of 144 thoracic cancer patients, label-free femtosecond imaging delivered diagnostic images in a median of 5.4 minutes versus 36.3 minutes for frozen sections, with lung tumor classification achieving an AUC of 0.95. Depth-scanning added three-dimensional margin insight, while early AI models for esophageal high-risk features showed modest accuracy and await larger validation.

Journal
JTCVS open (Q1)
Published
17 June 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Hao Yin, Fangyi Liu, Wendi Zhu, Wenlong Yu, Kunbo Zhang, Rongkui Luo, et al.
PMID
42604329
DOI
10.1016/j.xjon.2026.101930

Why clinicians should know about it

Abstract

OBJECTIVE: The study objective was to evaluate femtosecond label-free imaging combined with artificial intelligence as a rapid alternative to frozen-section pathology for intraoperative assessment in thoracic oncologic surgery. METHODS: This prospective study enrolled 144 patients undergoing resection for thoracic tumors at Shanghai Zhongshan Hospital (June to December 2025). Fresh specimens (259 lung, 96 esophageal) underwent femtosecond label-free imaging scanning using ultrashort laser pulses to generate multiple nonlinear optical signals (third harmonic generation, second harmonic generation, 2-photon and 3-photon fluorescence) without sectioning or staining. Deep learning algorithms were developed for lung tumor classification and exploratory high-risk feature prediction in esophageal squamous cell carcinoma. To avoid data leakage, specimen-level splits were adopted for lung tumor classification and patient-level splits for esophageal squamous cell carcinoma high-risk feature prediction. The models were constructed based on the pretrained UNI v1 foundation model combined with an attention-based multiple-instance learning framework, with data augmentation (flipping and rotation) applied during training. Performance was evaluated against conventional histopathology using receiver operating characteristic curve analysis, with data partitioned into training, validation, and test sets at a 7:1:2 ratio. RESULTS: Femtosecond label-free imaging demonstrated significant time advantage over frozen-section analysis (median 5.4 vs 36.3 minutes, P < .001). Morphological concordance with hematoxylin-eosin histology was achieved across tissue types. Artificial intelligence-based tumor classification achieved a mean area under the curve of 0.953 for lung specimens. Depth scanning at 3-μm intervals (up to 90 μm) enabled volumetric margin assessment, revealing depth-dependent tumor distribution variations not captured by single-plane frozen sections. Exploratory models predicted high-risk features in esophageal squamous cell carcinoma with a mean area under the curve of 0.653 to 0.766 for lymph node metastasis, perineural invasion, and lymphovascular invasion. CONCLUSIONS: Femtosecond label-free imaging provides rapid, morphologically concordant pathological assessment with significant workflow advantages over conventional frozen-section analysis. Depth-scanning capability addresses sampling limitations inherent to single-plane evaluation. Exploratory artificial intelligence models demonstrate feasibility for intraoperative prediction of high-risk pathological features in esophageal cancer; however, these results are preliminary and require validation in larger, multicenter cohorts before clinical deployment.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.